1,2-dimyristoylamido-1,2-deoxyphosphatidylcholine: artificial boundary lipid; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 130969 |
| MeSH ID | M0177954 |
| Synonym |
|---|
| 2,3-bis(tetradecanoylamino)propyl 2-(trimethylazaniumyl)ethyl phosphate |
| 1,2-ddpc |
| 3,5-dioxa-9-aza-4-phosphatricosan-1-aminium, 4-hydroxy-n,n,n-trimethyl-10-oxo-7-((1-oxotetradecyl)amino)-, hydroxide, inner salt, 4-oxide |
| 1,2-dimyristoylamido-1,2-deoxyphosphatidylcholine |
| 108861-07-0 |
| 4-hydroxy-n,n,n-trimethyl-10-oxo-7-((1-oxotetradecyl)amino)-3,5-dioxa-9-aza-4-phosphatricosan-1-aminium hydroxide, inner salt, 4-oxide |
| BLCRPWCTEAFGSY-UHFFFAOYSA-N , |
| 1,2-dimyristoylamido-1,2-deoxyphosphatidyl choline |
| 2,3-bis[(1-hydroxytetradecylidene)amino]propyl 2-(trimethylazaniumyl)ethyl phosphate |
| DTXSID10910888 |
| FT-0752384 |
| 2,3-ditetradecanamidopropyl 2-(trimethylammonio)ethyl phosphate |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.25) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||